semaglutide soul (Semaglutide cardiOvascular oUtcomes triaL) in individuals with Expanding cardiovascular indications for semaglutide:

doi:10.1016/j.cmet.2018.03.001 11

For example, at the time of the study, of those using GLP - 1 drugs for longer than one year, more than three-quarters said they were using the drug for health management, and less than one-quarter for weight loss

If you live with type 1 diabetes, chances are you've heard about GLP-1 medications Ozempic, Wegovy, Mounjaro mostly in the context of weight loss or type 2 diabetes

However, ONeil added an important caveat, reminding patients not to make too much of day-to-day gains or losses

It blocks that counter-signal, allowing bupropions appetite-reducing effect to stay switched on longer than it would on its own